Agios Pharmaceuticals INC.
Pharmaceutical company.
Based in MA
AI Overview
With $470K in lobbying spend across 13 quarterly filings, Agios Pharmaceuticals INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $150K |
| 2022 | $160K |
| 2023 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Agios Pharmaceuticals INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to the pharmaceutical industry.
Issues related to pharmaceutical pricing; Issues related to treatments for rare diseases.
H.R. 5376 - Build Back Better Act, Subtitle J, Issues related to pharmaceutical pricing and treatments for rare diseases.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.